This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Is SPDR S&P Global Dividend ETF (WDIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for WDIV
Top Stock Reports for Amgen, Eaton & Enzo Biochem
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc (ETN) and Sony Group Corp. (SONY), as well as two micro-cap stocks, Moving iMage Technologies, Inc. (MITQ) and Enzo Biochem, Inc. (ENZ).
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria Stock Reaches 52-Week High: Time to Capitalize or Wait?
by Ansuiya Mohta
Altria's smoke-free strategy and pricing power make it a compelling option for value-focused investors despite challenges from declining cigarette volumes.
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD
PM Stock Rallies 30% in 6 Months: What Should Investors Do Next?
by Ansuiya Mohta
Philip Morris is driving strong growth through its smoke-free transformation, supported by innovation, global expansion, pricing power, and disciplined cost management.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
The Zacks Analyst Blog Philip Morris, Altria and British American Tobacco
by Zacks Equity Research
Philip Morris, Altria and British American Tobacco are included in this Analyst Blog.
3 Tobacco Stocks to Watch as Smoke-Free Trends Ignite Growth
by Vrishali Bagree
Tobacco industry leaders like PM, MO and BTI are investing heavily in smoke-free products to align with health trends and regulatory shifts. Despite declining cigarette sales, strong pricing power and RRP growth support a sustainable outlook.
Here is What to Know Beyond Why Altria Group, Inc. (MO) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Company News for Nov 1, 2024
by Zacks Equity Research
Companies In The Article Are: MET,CI, BMY, MO
MO Q3 Earnings Top Estimates on Pricing Amid Low Cigarette Volumes
by Zacks Equity Research
Altria's Q3 results reflect strong pricing, while cigarette shipment volumes remain soft. Management announces the Optimize & Accelerate initiative.
Altria (MO) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 1.47% and 1.05%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Altria Stock a Buy, Sell or Hold at a P/S Multiple of 4.2X?
by Vrishali Bagree
Altria struggles with challenges in the Smokeable Products unit, driven by economic pressures on consumers and the rise of illegal e-vapor alternatives.
Should Altria Stock be in Your Portfolio Ahead of Q3 Earnings?
by Vrishali Bagree
Altria faces challenges from macroeconomic pressures and a surge in illegal e-vapor products, though smoke-free offerings provide some support.
Altria (MO) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Altria (MO) closed at $49.94, indicating a +0.28% shift from the previous trading day.
Altria (MO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Record Earnings: Should Investors Buy Philip Morris Stock Now?
by Ethan Feller
Philip Morris International has staged a massive rally on the back of its rapidly growing smokeless segment
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Altria (MO) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Altria (MO) concluded the recent trading session at $49.61, signifying a -0.26% move from its prior day's close.
Altria (MO) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $49.74, denoting a -0.84% change from the preceding trading day.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Is Trending Stock Altria Group, Inc. (MO) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.